Written by cpm
Download PDF The efficacy data needed for product registration doesn’t necessarily answer all the questions about the performance of a new active ingredient. CPM gets an insight on a series of trials which set out to test the boundaries of Revysol. The pressure exerted by 100M septoria spores/ml is akin to a nuclear strike to the plant. By Lucy de la Pasture The unique chemistry of Revysol (mefentrifluconazole) gives the new azole some key attributes that should translate into superior performance in the field. Tasked with finding out whether it would live up to expectation, ADAS senior research scientist Dr Julie Smith set out to test Revysol’s capabilities. “There are five main attributes that BASF believe Revysol has because of its chemistry. These are superior rainfastness and rapid uptake of the fungicide, contributing to strong curative activity; long lasting performance in the field; maintenance of efficacy under high disease pressure; effectiveness against DMI-adapted (insensitive) strains of septoria; and a benefit on resistant varieties,” explains Julie. To put Revysol through its paces she designed a series of field trials to tests these probable attributes, using it as a straight rather than the co-formulated product, Revystar (mefentriflucoazole+ fluxapyroxad), which is…
The post Rising to the septoria challenge appeared first on cpm magazine.
Continue reading on CPM website...
If you are enjoying what you read then why not considering subscribing:
